Structural Formula (Image 1)
Methotrexate Injection, Solution
Product Images NDC 0703-3671
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 0703-3671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Parenteral Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton 50mg-2ml (Image 2)
This is a description of Methotrexate Injection, USP, a cytotoxic drug that is used as an isotonic liquid for Intravenous, Intramuscular, Intrathecal, or Subcutaneous administration. It comes in a 2mL single-dose vial, containing 50 mg methotrexate, USP, and is preservative-free and sterile. The drug should be discarded if unused. The inactive ingredients include sodium chloride, may contain hydrochloric acid and/or sodium hydroxide to adjust the pH. The product is manufactured in the Netherlands by Pharmachemie BY and is manufactured for Teva Pharmaceuticals USA, Inc. It also includes a warning to see the package insert for full prescribing information and boxed warnings. It should be stored at 20° to 25° Celsius and protected from light. The text includes a serialized coding area, but does not provide any meaningful information.*
Carton 250mg-10ml (Image 3)
This is a description of a medicine labeled as Methotrexate Injection, USP. It is a 250mg/10mL isotonic liquid cytotoxic agent that can be administered through various means such as intravenous, intramuscular, intrathecal, or subcutaneous injections. The medicine comes in a 10mL single-dose vial and must be discarded after its use. It is manufactured by Pharmacheme BY in Haarlem, The Netherlands, and is distributed in the United States by Teva Pharmaceuticals USA Inc. The active ingredient of Methotrexate Injection, USP is methotrexate, and each vial contains 250mg of it. Some of the inactive ingredients present in the medicine may include sodium chloride, sodium hydroxide, and/or hydrochloric acid.*
Carton 1g-40ml (Image 4)
This is a medication called Methotrexate that is available in a 40mL single-dose vial, with 25 mg/mL concentration as an isotonic liquid for intravenous, intramuscular, intrathecal, and subcutaneous administration. The drug is considered a cytotoxic agent and does not contain preservatives. The vial must be discarded after use, and the medication should be kept at a controlled temperature between 20°C to 25°C while protecting it from light. The vial contains 1,000 mg of methotrexate, with inactive sodium chloride (196 mg), and the pH adjusted to 8.5 with sodium hydroxide and/or hydrochloric acid. The manufacturer is Pharmachemie BV in Haarlem, Netherlands, produced for Teva Pharmaceuticals USA in Parsippany, NJ. The packaging insert and warnings should be carefully read before using this medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
